|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Dec―19 |
NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare Database |
Jonathan F. Brozat, Fady Ntanios, Deepa Malhotra, Simon Dagenais, Nino Katchiuri, Birol Emir, Frank Tacke |
2 |
[GO] |
2023―Sep―22 |
Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach |
Loreta A. Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla, Valentina Gallinaro, et al. (+2) Gianpiero D'Offizi, Antonio Craxì |
3 |
[GO] |
2023―Sep―22 |
Ursodeoxycholic acid does not affect the clinical outcome of SARS-CoV-2 infection: A retrospective study of propensity score-matched cohorts |
Giuseppe Marrone, Marcello Covino, Giuseppe Merra, Andrea Piccioni, Annamaria Amodeo, Angela Novelli, et al. (+4) Rita Murri, Maurizio Pompili, Antonio Gasbarrini, Francesco Franceschi |
4 |
[GO] |
2023―Jun―30 |
Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021 |
Donghee Kim, Richie Manikat, George Cholankeril, Aijaz Ahmed |
5 |
[GO] |
2023―Jun―29 |
Ursodeoxycholic acid administration did not reduce susceptibility to SARS-CoV-2 infection in children |
Teng Liu, Jian-She Wang |
6 |
[GO] |
2023―Mar―17 |
Third dose of
SARS-CoV2 mRNA
vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients |
Marzia Montalbano, Paola Piccolo, Raffaella Lionetti, Ubaldo Visco-Comandini, Chiara Agrati, Germana Grassi, et al. (+12) Silvia Meschi, Giulia Matusali, Federica Conte, Federica Angelone, Giuseppe Maria Ettorre, Nicola Guglielmo, Fabrizio Maggi, Massimo Francalancia, Tiziana Mereu, Vincenzo Puro, Enrico Girardi, Gianpiero D’Offizi |
7 |
[GO] |
2022―Sep―06 |
No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan |
Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio |
8 |
[GO] |
2022―Aug―25 |
No impact of Covid-19 epidemic on decompensation of alcoholic liver disease: results from a single-center in Milan |
Masetti Chiara, Colapietro Francesca, Voza Antonio, Aghemo Alessio |
9 |
[GO] |
2022―Aug―20 |
Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: a systematic review and meta-analysis |
De Luo, Xinpei Chen, Juan Du, Bingjie Mei, Ankang Wang, Fei Kuang, et al. (+7) Cheng Fang, Yu Gan, Fangyi Peng, Xiaoli Yang, Uta Dahmen, Bo Li, Su Song |
10 |
[GO] |
2022―Jul―23 |
HCV
point of care screening in people tested for
SARS-CoV
-2 in a social-housing neighbourhood of Milan, Italy |
Martina Beltrami, Gabriele Pagani, Federico Conti, Laura Pezzati, Giacomo Casalini, Rossana Rondanin, et al. (+4) Andrea Prina, Antonino Zagari, Massimo Galli, Andrea Giacomelli |
11 |
[GO] |
2022―Jul―20 |
Third Dose of mRNA COVID-19 Vaccine and response: Correspondence |
Pathum Sookaromdee, Viroj Wiwanitkit |
12 |
[GO] |
2022―Jun―28 |
Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine - no longer exclusive to mRNA vaccine? |
Shahreedhan Shahrani, Sooi Choong Yeong, Ida Normiha Hilmi, Sanjiv Mahadeva |
13 |
[GO] |
2022―Jun―09 |
Mycophenolate and
SARS-CoV
-2 vaccination: Mixing oil and water |
Marisol Arenas-De Larriva, Manuel L. Rodríguez-Perálvarez |
14 |
[GO] |
2022―Jun―09 |
Sars-Cov
-2 vaccination in liver transplant recipients: The ‘holy grail’ in a hostile environment |
Patrizia Burra, Francesco Paolo Russo |
15 |
[GO] |
2022―Jun―07 |
Response to: “No Impact of Covid-19 Pandemic on Decompensation of Alcoholic Liver Disease: Results from a Single Center in Milan” |
Humberto C. Gonzalez, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon |
16 |
[GO] |
2022―May―28 |
Screening for hepatitis C at the time of the pandemic: Need to adjust the shot |
Pietro Torre, Carmine Coppola, Mario Masarone, Marcello Persico |
17 |
[GO] |
2022―May―24 |
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study |
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jordi Bruix, Marco Sanduzzi-Zamparelli, José Ríos, et al. (+49) Mohamed Bouattour, Mohamed El-Kassas, Cassia R. G. Leal, Tudor Mocan, Jean-Charles Nault, Rogerio C. P. Alves, Helen L. Reeves, Leonardo da Fonseca, Ignacio García-Juárez, David J. Pinato, María Varela, Saleh A. Alqahtani, Mario R. Alvares-da-Silva, Juan C. Bandi, Lorenza Rimassa, Mar Lozano, Jesús M. González Santiago, Frank Tacke, Margarita Sala, María Anders, Anja Lachenmayer, Federico Piñero, Alex França, Maria Guarino, Alessandra Elvevi, Giuseppe Cabibbo, Markus Peck-Radosavljevic, Ángela Rojas, Mercedes Vergara, Chiara Braconi, Sonia Pascual, Christie Perelló, Vivianne Mello, Carlos Rodríguez-Lope, Juan Acevedo, Rosanna Villani, Clemence Hollande, Valérie Vilgrain, Ahmed Tawheed, Carmem Ferguson Theodoro, Zeno Sparchez, Lorraine Blaise, Daniele E. Viera-Alves, Robyn Watson, Flair J. Carrilho, Carlos Moctezuma-Velázquez, Antonio D'Alessio, Massimo Iavarone, Maria Reig |
18 |
[GO] |
2022―Apr―08 |
Hepatitis C screening during
SARS-CoV
-2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno |
Pietro Torre, Monica Annunziata, Roberta Sciorio, Carmine Coppola, Mario Masarone, Marcello Persico |
19 |
[GO] |
2022―Mar―28 |
Quality of life in liver transplant recipients during the Corona Virus Disease 19 pandemic: a multicenter study |
Stefano Gitto, Lucia Golfieri, Nicolò Mannelli, Maria Rosa Tamè, Ivo Lopez, Roberta Ceccato, et al. (+45) Stanislao Montanari, Margherita Falcini, Giovanni Vitale, Nicola Maria, Danilo Lo Presti, Luca Marzi, Andrea Mega, Giovanna Valente, Alberto Borghi, Francesco Giuseppe Foschi, Silvana Grandi, Paolo Forte, Matteo Cescon, Fabrizio Di Benedetto, Pietro Andreone, Giulio Arcangeli, Paolo De Simone, Andrea Bonacchi, Francesco Sofi, Maria Cristina Morelli, Marco Petranelli, Chloe Lau, Fabio Marra, Francesca Chiesi, Francesco Vizzutti, Vittoria Vero, Roberto Di Donato, Sonia Berardi, Paolo Pianta, Sharon D’Anzi, Filippo Schepis, Noemi Gualandi, Francesca Miceli, Erica Villa, Guido Piai, Marco Valente, Claudia Campani, Erica Lynch, Paolo Magistri, Carmela Cursaro, Anna Chiarelli, Paola Carrai, Stefania Petruccelli, Monica Dinu, Giuditta Pagliai |
20 |
[GO] |
2022―Mar―26 |
Mycophenolate mofetil decreases humoral responses to three doses of
SARS-CoV
-2 vaccine in liver transplant recipients |
Lucy Meunier, Mathilde Sanavio, Jérôme Dumortier, Magdalena Meszaros, Stéphanie Faure, José Ursic Beodya, et al. (+4) Maxime Echenne, Olivier Boillot, Antoine Debourdeau, Georges Philippe Pageaux |
21 |
[GO] |
2022―Feb―23 |
Nintedanib induced liver injury: Not every liver injury is virus or vaccine-induced in the era of COVID-19 |
Anuraag Jena, Tanushi Aggarwal, Suvradeep Mitra, Anupam Kumar Singh |
22 |
[GO] |
2022―Feb―07 |
Vaccination against COVID-19 decreases hospitalizations in patients with cirrhosis: Results from a nationwide analysis |
Luis Antonio Díaz, Eduardo Fuentes-López, Mariana Lazo, Patrick S. Kamath, Marco Arrese, Juan Pablo Arab |
23 |
[GO] |
2022―Feb―02 |
Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection |
Taiyu He, Yingzhi Zhou, Pan Xu, Ning Ling, Min Chen, Tianquan Huang, et al. (+28) Biqiong Zhang, Ziqiao Yang, Ling Ao, Hu Li, Zhiwei Chen, Dazhi Zhang, Xiaofeng Shi, Yu Lei, Zhiyi Wang, Weiqun Zeng, Peng Hu, Yinghua Lan, Zhi Zhou, Juan Kang, Ying Huang, Tongdong Shi, Qingbo Pan, Qian Zhu, Xiping Ran, Yingzhi Zhang, Rui Song, Dejuan Xiang, Shuang Xiao, Gaoli Zhang, Wei Shen, Mingli Peng, Dachuan Cai, Hong Ren |
24 |
[GO] |
2022―Jan―30 |
Alcohol-related hepatitis admissions increased 50% in the first months of the
CoViD
-19 pandemic in the
US |
Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, Loralee B Rupp, Sheri Trudeau, Stuart C Gordon |
25 |
[GO] |
2022―Jan―29 |
Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19? |
Benedetta Terziroli Beretta-Piccoli, Ana Lleo |
26 |
[GO] |
2022―Jan―07 |
Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease |
Hideki Fujii, Naotoshi Nakamura, Shinya Fukumoto, Tatsuo Kimura, Akemi Nakano, Yuji Nadatani, et al. (+6) Yukie Tauchi, Yuuko Nishii, Shingo Takashima, Yoshihiro Kamada, Toshio Watanabe, Norifumi Kawada |
27 |
[GO] |
2021―Dec―16 |
Is it time to get rid of the biopsy mandate in adults with suspected Autoimmune hepatitis? Lessons from the COVID-19 pandemic. |
Ali Ibrahim Shorbagi |
28 |
[GO] |
2021―Nov―30 |
Effects of Immunosuppressive Drugs on COVID-19 severity in Patients with Autoimmune Hepatitis |
Cumali Efe, Craig Lammert, Koray Taşçılar, Renumathy Dhanasekaran, Berat Ebik, Fatima Higuera-de la Tijera, et al. (+74) Ali Rıza Calışkan, Mirta Peralta, Alessio Gerussi, Hatef Massoumi, Andreea M. Catana, Tugrul Purnak, Cristina Rigamonti, Andres Jose Gomez Aldana, Nidah Khakoo, Leyla Nazal, Shalom Frager, Nurhan Demir, Kader Irak, Zeynep Melekoğlu Ellik, Hüseyin Kacmaz, Yasemin Balaban, Kadri Atay, Fatih Eren, Mario Reis Alvares-da-Silva, Laura Cristoferi, Álvaro Urzua, Tuğçe Eşkazan, Bianca Magro, Romee Snijders, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Aylin Demirezer Bolat, Mesut Aydın, Alexandra Heurgue-Berlot, Eleonora De Martin, Nazım Ekin, Sümeyra Yıldırım, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Murat Kıyıcı, Murat Akyıldız, Evrim Kahramanoğlu-Aksoy, Maria Vincent, Rotonya M Carr, Fulya Günşar, Eira Cerda Reyes, Murat Harputoğlu, Costica Aloman, Nikolaos K. Gatselis, Yücel Üstündağ, Javier Brahm, Nataly Chris Escajadillo Vargas, Fatih Güzelbulut, Sandro Ruiz Garcia, Jonathan Aguirre, Margarita Anders, Natalia Ratusnu, Ibrahim Hatemi, Manuel Mendizabal, Annarosa Floreani, Stefano Fagiuoli, Marcelo Silva, Ramazan Idilman, Sanjaya K. Satapathy, Marina Silveira, Joost P. H. Drenth, George N Dalekos, David N. Assis, Einar Björnsson, James L. Boyer, Eric M. Yoshida, Pietro Invernizzi, Cynthia Levy, Aldo J. Montano-Loza, Thomas D. Schiano, Ezequiel Ridruejo, Staffan Wahlin |
29 |
[GO] |
2021―Nov―01 |
A typical autoimmune hepatitis (AIH) case following Covid-19 mRNA vaccination. More than a coincidence? |
Anestis Goulas, Georgia Kafiri, Hariklia Kranidioti, Spilios Manolakopoulos |
30 |
[GO] |
2021―Oct―31 |
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients |
Gianpiero D’Offizi, Chiara Agrati, Ubaldo Visco-Comandini, Concetta Castilletti, Vincenzo Puro, Paola Piccolo, et al. (+12) Montalbano Marzia, Silvia Meschi, Eleonora Tartaglia, Chiara Sorace, Sara Leone, Daniele Lapa, Germana Grassi, Delia Goletti, Giuseppe Ippolito, Francesco Vaia, Giuseppe Maria Ettorre, Raffaella Lionetti |
31 |
[GO] |
2021―Oct―08 |
Reshape and secure HCC managing during COVID-19 pandemic: a single center analysis of four periods in 2020 versus 2019 |
Massimo Iavarone, Barbara Antonelli, Anna Maria Ierardi, Matilde Topa, Angelo Sangiovanni, Andrea Gori, et al. (+4) Chiara Oggioni, Giorgio Rossi, Gianpaolo Carrafiello, Pietro Lampertico |
32 |
[GO] |
2021―Oct―07 |
Aspartate aminotransferase in COVID-19: A probably overrated marker |
Elena Aloisio, Mauro Panteghini, Luca Valenti |
33 |
[GO] |
2021―Sep―30 |
Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: an interrupted time series analysis |
Mawuena Binka, Sofia Bartlett, Héctor Alexander Velásquez García, Maryam Darvishian, Dahn Jeong, Prince Adu, et al. (+7) Maria Alvarez, Stanley Wong, Amanda Yu, Hasina Samji, Mel Krajden, Jason Wong, Naveed Zafar Janjua |
34 |
[GO] |
2021―Sep―23 |
COVID-19, adaptative immune response and metabolic associated liver disease |
Luca Miele, Cecilia Napodano, Alfredo Cesario, Antonio De Magistris, Krizia Pocino, Umberto Basile, et al. (+3) Gian Ludovico Rapaccini, Antonio Gasbarrini, Antonio Grieco |
35 |
[GO] |
2021―Sep―03 |
Autoimmune hepatitis triggered by COVID-19: A report of two cases |
Gökhan Kabaçam, Staffan Wahlin, Cumali Efe |
36 |
[GO] |
2021―Aug―29 |
PNPLA3
and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system |
Carlos J Pirola, Silvia Sookoian |
37 |
[GO] |
2021―Jul―05 |
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: a web-based survey |
Francesca Romana Ponziani, Alessio Aghemo, Giuseppe Cabibbo, Mario Masarone, Sara Montagnese, Salvatore Petta, et al. (+55) Francesco Paolo Russo, Quirino Lai, Maria Oliva Pensi, Marta Tonon, Daniela Campion, Tommaso Maria Manzia, Renato Finazzi, Giorgio Soardo, Stefano Fagiuoli, Ana Lleo, Lorenzo Nosotti, Ludovico Abenavoli, Salvatore D'Angelo, Sara Montagnese, Maria Rendina, Patrizia Cocco, Simona Francioso, Paolo Caraceni, Silvia Martini, Raffaele Cozzolongo, Giovan Giuseppe Di Costanzo, Salvatore Stefano Sciarrone, Marcello Bianchini, Paola Piccolo, Pietro Andreone, Antonio Liguori, Silvia Gaia, Mauro Sapienza, Mariarosa Tamè, Mariagrazia Rumi, Luchino Chessa, Vito Sansone, Gabriella Verucchi, Enrico Gringeri, Giuseppina Renier, Rachele Rapetti, Monica Cucco, Edoardo Giovanni Giannini, Carlo Saitta, Ludovico Abenavoli, Ubaldo Visco Comandini, Anna Fracanzani, Angelo Salomone Megna, Maria Teresa Falce, Irene Franceschet, Natalia Terreni, Chiara Ferrara, Michele Campigotto, Simona Parisse, Giulia Morsica, Monica Moretti, Adriana Giorgi, Nadia Trancanella, Stefano Abbruzzese, Dario D’Agostino |
38 |
[GO] |
2021―Jun―22 |
COVID-19 and the liver - Lessons learned |
Toni Herta, Thomas Berg |
39 |
[GO] |
2021―Jun―21 |
COVID-19 And The Liver: a 2021 Update |
CW Spearman, A Aghemo, L Valenti, MW Sonderup |
40 |
[GO] |
2021―Jun―01 |
Hepatitis C Elimination in Sweden: Progress, Challenges and Opportunities for Growth in the time of COVID-19 |
S Blach, M Blomé, A-S Duberg, A Jerkeman, M Kåberg, P-E Klasa, et al. (+4) M Lagging, D Razavi-Shearer, H Razavi, S Aleman |
41 |
[GO] |
2021―May―21 |
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19 |
Simon Bütikofer, Daniela Lenggenhager, Pedro David Wendel Garcia, Ewerton Marques Maggio, Martina Haberecker, Cäcilia S. Reiner, et al. (+6) Gregor Brüllmann, Karl Philipp Bühler, Christoph Gubler, Beat Müllhaupt, Christoph Jüngst, Bernhard Morell |
42 |
[GO] |
2021―Apr―07 |
Liver involvement in Children with SARS-COV-2 Infection: Two Distinct Clinical Phenotypes Caused by the Same Virus |
Adriana Pere, Amanda Cantor, Bryan Rudolph, Jonathan Miller, Debora Kogan-Liberman, Qi Gao, et al. (+4) Bernardo Da Silva, Kara Gross Margolis, Nadia Ovchinsky, Mercedes Martinez |
43 |
[GO] |
2021―Feb―05 |
Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection |
Adeel A. Butt, Peng Yan, Rashid A. Chotani, Obaid S. Shaikh |
44 |
[GO] |
2020―Dec―23 |
Clinical Characteristics of COVID-19 Patients with Hepatitis B Virus Infection - a Retrospective Study |
Rui Liu, Li Zhao, Xiaoming Cheng, Han Huan, Cong Li, Dong Li, et al. (+7) Andrew Liu, Guosheng Gao, Feng Zhou, Fang Liu, Yingan Jiang, Chengliang Zhu, Yuchen Xia |
45 |
[GO] |
2020―Nov―17 |
Genetic insight into COVID-19 related liver injury: a note on
MBOAT7 |
Antonia Machill, Robert Bals, Frank Lammert, Marcin Krawczyk |
46 |
[GO] |
2020―Nov―15 |
Pathophysiological mechanisms of liver injury in COVID-19 |
Alexander D. Nardo, Mathias Schneeweiss-Gleixner, May Bakail, Emmanuel D. Dixon, Sigurd F. Lax, Michael Trauner |
47 |
[GO] |
2020―Nov―07 |
COVID-19 and liver disease: not all evil comes to harm |
Elisa Marabotto, Sebastiano Ziola, Afscin Djahandideh Sheijani, Edoardo G. Giannini |
48 |
[GO] |
2020―Oct―24 |
Genetic insight into Covid-19 related liver injury |
Cristiana Bianco, Guido Baselli, Francesco Malvestiti, Luigi Santoro, Serena Pelusi, Maria Manunta, et al. (+5) Giacomo Grasselli, Alessandra Bandera, Luigia Scudeller, Daniele Prati, Luca Valenti |
49 |
[GO] |
2020―Oct―02 |
Rates and Characteristics of SARS-CoV-2 Infection in Persons with Hepatitis C Virus Infection |
Adeel A. Butt, Peng Yan |
50 |
[GO] |
2020―Jul―17 |
Value-based medicine, a compass to guide health care decisions in the COVID-19 aftermath |
Mario Strazzabosco |
51 |
[GO] |
2020―Jul―17 |
Running out of bullets: the challenging management of acute hepatitis and SARS-COV-2 from the SMatteo COvid19 Registry (SMACORE) |
Marta Colaneri, Pietro Valsecchi, Luciano Perotti, Serena Ludovisi, Elena Seminari, Teresa Chiara Pieri, et al. (+2) Paolo Sacchi, Raffaele Bruno |
52 |
[GO] |
2020―Jun―25 |
Impact of Chronic Liver Disease on Outcomes of Hospitalized Patients with COVID-19: A Multicenter United States Experience |
Nikroo Hashemi, Kathleen Viveiros, Walker D. Redd, Joyce C. Zhou, Thomas R. McCarty, Ahmad Najdat Bazarbashi, et al. (+5) Kelly E. Hathorn, Danny Wong, Cheikh Njie, Lin Shen, Walter W. Chan |
53 |
[GO] |
2020―Jun―23 |
Metabolic associated fatty liver disease is associated with severity of COVID-19 |
Yu-Jie Zhou, Kenneth I. Zheng, Xiao-Bo Wang, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, et al. (+4) Hong-Lei Ma, Yong-Ping Chen, Jacob George, Ming-Hua Zheng |
54 |
[GO] |
2020―Jun―19 |
Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease |
Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng |
55 |
[GO] |
2020―Jun―11 |
Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19 |
Salvatore Piano, Andrea Dalbeni, Elia Vettore, Devis Benfaremo, Massimo Mattioli, Carmine Gabriele Gambino, et al. (+25) Viviana Framba, Lorenzo Cerruti, Anna Mantovani, Andrea Martini, Michele Maria Luchetti, Roberto Serra, Annamaria Cattelan, Roberto Vettor, Paolo Angeli, Gaetano Arcidiacono, Silvia Bettini, Benedetta Maria Bonora, Giovanni Bucca, Armando Gabrielli, Francesca Ghirardini, Umberto Gnudi, Sara Mareso, Marco Marini, Luciano Mucci, Gian Piero Perna, Fabio Presotto, Caterina Sensi, Francesco Soliani, Roberta Stupia, Mirko Zoncapè |
56 |
[GO] |
2020―Jun―11 |
A letter of solidarity during the COVID-19 Pandemic |
Jeffrey V. Lazarus, Francesco Negro, Manal El-Sayed, Massimo Colombo |
57 |
[GO] |
2020―Jun―04 |
Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry? |
Magdalena Meszaros, Lucy Meunier, David Morquin, Kada Klouche, Pierre Fesler, Emilie Malezieux, et al. (+4) Alain Makinson, Vincent le Moing, Jacques Reynes, Georges-Philippe Pageaux |
58 |
[GO] |
2020―May―29 |
Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience |
Anita Verma, Shirin Elizabeth Khorsandi, Annalisa Dolcet, Andreas Prachalias, Abid Suddle, Nigel Heaton, Wayel Jassem |
59 |
[GO] |
2020―May―23 |
Can thrombotic events be a major concern in hepatocellular carcinoma patients under systemic treatment during SARS-Cov-2? |
Leonardo da Fonseca, Flair José Carrilho |
60 |
[GO] |
2020―May―21 |
SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure |
Karsten Große, Matthijs Kramer, Christian Trautwein, Tony Bruns |
61 |
[GO] |
2020―May―20 |
COVID-19 and liver cancer clinical trials: not everything is lost |
Antonio D’Alessio, Nicola Personeni, Tiziana Pressiani, Silvia Bozzarelli, Valeria Smiroldo, Matteo Simonelli, et al. (+3) Ana Lleo, Armando Santoro, Lorenza Rimassa |
62 |
[GO] |
2020―May―17 |
First case of drug-induced liver injury (DILI) associated with the use of tocilizumab in a patient with COVID-19 |
Damir Muhović, Jelena Bojović, Ana Bulatović, Batrić Vukčević, Marina Ratković, Ranko Lazović, Brigita Smolović |
63 |
[GO] |
2020―May―16 |
Management of Hepatocellular Cancer in the time of SARS-CoV-2 |
Rohini Sharma, David J. Pinato |
64 |
[GO] |
2020―May―11 |
Liver injury in COVID-19: diagnosis and associated factors - authors' reply |
Ningfang Lian, Su Lin, Hansheng Xie |
65 |
[GO] |
2020―May―05 |
Acute on Chronic Liver Failure from Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
He Qiu, Praneet Wander, David Bernstein, Sanjaya K. Satapathy |
66 |
[GO] |
2020―May―02 |
Liver injury in COVID-19: diagnosis and associated factors |
Zheng Ye, Bin Song |
67 |
[GO] |
2020―Apr―30 |
SARS-CoV-2 virus and liver expression of host receptors: Putative mechanisms of liver involvement in COVID-19 |
Carlos J Pirola, Silvia Sookoian |
68 |
[GO] |
2020―Apr―29 |
Author response to Letter to the Editor “Liver impairment associated with disease progression in COVID-19 patients” |
Yafei Zhang, Lan Liu, Qiu Zhao |
69 |
[GO] |
2020―Apr―22 |
COVID-19 and viral hepatitis elimination programs: Are we stepping backward? |
Hamidreza Karimi-Sari, Mohammad Saeid Rezaee-Zavareh |
70 |
[GO] |
2020―Apr―19 |
Potential implications of COVID-19 in non-alcoholic fatty liver disease |
Grietje H. Prins, Peter Olinga |
71 |
[GO] |
2020―Apr―18 |
Bilirubin levels in patients with mild and severe Covid-19: a pooled analysis |
Panagiotis Paliogiannis, Angelo Zinellu |
72 |
[GO] |
2020―Apr―15 |
Liver impairment associated with disease progression in COVID-19 patients |
Peng Chen, Jiexin Lei, Yue Wu, Gang Liu, Benhong Zhou |
73 |
[GO] |
2020―Apr―06 |
COVID-19 and liver disease |
Jian Sun, Alessio Aghemo, Alejandro Forner, Luca Valenti |
74 |
[GO] |
2020―Apr―05 |
Coronavirus disease 2019 (COVID-19) and prevalence of chronic liver disease: A meta-analysis |
Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni |
75 |
[GO] |
2020―Apr―05 |
Let’s not forget our COVID-19-free cirrhotic patients! |
Mauro Viganò, Marco Carbone |
76 |
[GO] |
2020―Apr―02 |
Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China |
Yafei Zhang, Liang Zheng, Lan Liu, Mengya Zhao, Jun Xiao, Qiu Zhao |
77 |
[GO] |
2020―Apr―02 |
Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury:A Retrospective study |
Hansheng Xie, Jianming Zhao, Ningfang Lian, Su Lin, Qunfang Xie, Huichang Zhuo |
78 |
[GO] |
2020―Mar―14 |
Liver injury during highly pathogenic human coronavirus infections |
Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng |
|